Font, P.
1478  Ergebnisse:
Personensuche X
?
2

Clinical application of flow cytometry in patients with une..:

Loosdrecht, A.A ; Kern, W ; Porwit, A...
Loosdrecht , A A , Kern , W , Porwit , A , Valent , P , Kordasti , S , Cremers , E , Alhan , C , Duetz , C , Dunlop , A , Hobo , W , Preijers , F , Wagner-Ballon , O , Chapuis , N , Fontenay , M , Bettelheim , P , Eidenschink-Brodersen , L , Font , P , Johansson , U , Loken , M R , Marvelde , J G , Matarraz , S , Ogata , K , Oelschlaegel , U , Orfao , A , Psarra , K , Subira , D , Wells , D A , Bene , M C , Della Porta , M G , Burbury , K , Bellos , F , van der Velden , V H J , Westers , T M , Saft , L & Ireland , R 2021 , ' Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group ' , Cytometry Part B-clinical Cytometry . https://doi.org/10.1002/cyto.b.22044.  , 2021
 
?
5

Flow cytometric analysis of myelodysplasia: Pre-analytical ..:

van der Velden, V.H.J ; Preijers, F ; Johansson, U...
van der Velden , V H J , Preijers , F , Johansson , U , Westers , T M , Dunlop , A , Porwit , A , Bene , M C , Valent , P , te Marvelde , J , Wagner-Ballon , O , Oelschlaegel , U , Saft , L , Kordasti , S , Ireland , R , Cremers , E , Alhan , C , Duetz , C , Hobo , W , Chapuis , N , Fontenay , M , Bettelheim , P , Eidenshink-Brodersen , L , Font , P , Loken , M R , Matarraz , S , Ogata , K , Orfao , A , Psarra , K , Subira , D , Wells , D A , Della Porta , M G , Burbury , K , Bellos , F , Weiss , E , Kern , W & van de Loosdrecht , A 2021 , ' Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet ' , Cytometry Part B-clinical Cytometry . https://doi.org/10.1002/cyto.b.22046.  , 2021
 
?
6

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for Fi..:

Mareque M ; Montesinos P ; Font P...
https://www.dovepress.com/cost-effectiveness-analysis-of-gemtuzumab-ozogamicin-for-first-line-tr-peer-reviewed-fulltext-article-CEOR.  , 2021
 
?
7

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for Fi..:

Mareque M ; Montesinos P ; Font P...
https://www.dovepress.com/corrigendum-cost-effectiveness-analysis-of-gemtuzumab-ozogamicin-for-f-peer-reviewed-fulltext-article-CEOR.  , 2021
 
?
9

Multiwavelength Observations of the Blazar VER J0521+211 du..:

Adams, CB ; Batista, P ; Benbow, W...
info:eu-repo/semantics/altIdentifier/wos/WOS:000816875100001.  , 2022
 
?
11

Periastron Observations of TeV Gamma-Ray Emission from a Bi..:

Abeysekara, A. U ; Benbow, W ; Bird, R...
info:eu-repo/semantics/altIdentifier/wos/WOS:000448968100003.  , 2018
 
?
13

MAGIC detection of short-term variability of the high-peake..:

Aleksić, J ; Ansoldi, S ; Antonelli, L. A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000360827800057.  , 2015
 
?
 
?
15

MAGIC Observations and Multifrequency Properties of the Fla..:

Aleksić, J ; Ansoldi, S ; Berger, K...
info:eu-repo/semantics/altIdentifier/doi/10.1051/0004-6361/201323036.  , 2014
 
1-15